Skip to main content
NeuronFeed

Nucleo vs Truveta

Which Healthcare AI tool is better in 2026?

Nucleo

The first Agentic platform for Oncology

$500K

Truveta

$515M

Side-by-side

Verdict

Truveta is the more established option (raised $515M); pricing is comparable on both sides.

Metric Nucleo Truveta
Taglinei The first Agentic platform for Oncology
Foundedi 2025 2020🏆
HQi
Employeesi 1-10 11-50🏆
Neuron scorei 44 75🏆
Total fundingi $500K $515M🏆
Latest roundi Seed · Jan 2025 Series C · Jan 2025
Valuationi $1B🏆
Cheapest paid plani Pricing not disclosed Pricing not disclosed
Free plani
Free triali
Top tier pricei Pricing not disclosed Pricing not disclosed
Pricing summaryi Pricing not listed Free
Categoriesi

Capability matrix

Developer-facing capabilities and access signals for Nucleo and Truveta.

Capability Nucleo Truveta
MCP support
Public API
Webhooks
OAuth 2.0
SDK languages
Free plan
Free trial
Verified
Active deal

🟢 Strengths of Nucleo

  • Newer company (2025)

🔵 Strengths of Truveta

  • Has raised more capital ($515M vs $500K)
  • Higher Neuron score (75 vs 44)
  • Offers a free plan
  • Offers a free trial

Which should you choose?

Choose Truveta if price matters most — it starts at Free, which is friendlier for teams watching burn. Both AI Healthcare tools ship core features, so the cost delta often decides it for small teams and solo operators.

Choose Truveta if you want the most established option — it has raised $515M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.

Frequently asked questions

Nucleo vs Truveta — which is better?

It depends on your priority. Nucleo is the leaner option; Truveta has broader feature depth. See the side-by-side table above.

Is Nucleo cheaper than Truveta?

No — Truveta's cheapest paid plan is Free, while Nucleo's is Pricing not listed.

Do Nucleo and Truveta offer free plans?

Nucleo: Paid only. Truveta: Yes, has a free plan.

Contextual paths to related AI startups, deals and rankings.